Opioid Management in Pregnancy and Postpartum

Area of Science:

• Perinatal care
• Addiction medicine
• Maternal-fetal medicine

Background:

• Opioid use disorder (OUD) in pregnant and postpartum women poses significant challenges in perinatal care.
• These women often face stigma, leading to inadequate prenatal and postpartum care and increased risks for complications.
• Infants born to mothers with OUD are at high risk for neonatal abstinence syndrome (NAS) and may require neonatal intensive care.

Purpose of the Study:

• To highlight the challenges in perinatal care for women with opiate use disorder.
• To emphasize the need for sensitive, compassionate, and evidence-based care.
• To underscore the importance of specialized pain management and postpartum follow-up.

Main Methods:

• This abstract summarizes key considerations for healthcare teams managing pregnant and postpartum women with opiate use disorder.
• It emphasizes a multidisciplinary approach involving addiction specialists.
• Focuses on evidence-based practices for prenatal, delivery, and postpartum care.

Main Results:

• Women with opiate use disorder are at increased risk for poor maternal and infant outcomes.
• Infants are highly susceptible to neonatal abstinence syndrome, often necessitating neonatal intensive care.
• Effective pain management during labor and delivery is crucial and requires expert consultation.

Conclusions:

• Healthcare teams must provide sensitive, stigma-free, evidence-based care for pregnant and postpartum women with opiate use disorder.
• Collaboration with addiction specialists is essential for optimal pain management and treatment.
• Comprehensive postpartum follow-up is critical for the well-being of both mother and child.